-
EP4126825
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4126825
| EP4126825 - AMINOCYCLOBUTANES AS MONOACYLGLYCEROL LIPASE MODULATORS [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 06.01.2023 Database last updated on 22.01.2025 | |
| Former | The international publication has been made Status updated on 02.10.2021 | ||
| Former | unknown Status updated on 10.04.2021 | Most recent event Tooltip | 16.02.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states Janssen Pharmaceutica NV Turnhoutseweg 30 2340 Beerse / BE | [2023/06] | Inventor(s) | 01 /
AMERIKS, Michael K. 3210 Merryfield Row San Diego, California 92121 / US | 02 /
GARCIA-REYNAGA, Pablo 3210 Merryfield Row San Diego, California 92121 / US | [2023/06] | Representative(s) | Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB | [2023/06] | Application number, filing date | 21715558.9 | 25.03.2021 | [2023/06] | WO2021EP57838 | Priority number, date | US202063000298P | 26.03.2020 Original published format: US 202063000298 P | [2023/06] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2021191391 | Date: | 30.09.2021 | Language: | EN | [2021/39] | Type: | A1 Application with search report | No.: | EP4126825 | Date: | 08.02.2023 | Language: | EN | The application published by WIPO in one of the EPO official languages on 30.09.2021 takes the place of the publication of the European patent application. | [2023/06] | Search report(s) | International search report - published on: | EP | 30.09.2021 | Classification | IPC: | C07D263/52, A61K31/423, A61P25/00, A61P27/02, A61P35/00 | [2023/06] | CPC: |
C07D263/52 (EP,KR,US);
A61K31/423 (KR);
A61P25/00 (EP,KR);
A61P27/02 (EP,KR);
A61P29/00 (KR);
A61P35/00 (EP,KR)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/06] | Extension states | BA | 25.10.2022 | ME | 25.10.2022 | Validation states | KH | 25.10.2022 | MA | 25.10.2022 | MD | 25.10.2022 | TN | 25.10.2022 | Title | German: | AMINOCYCLOBUTANE ALS MONOACYLGLYCEROL-LIPASEMODULATOREN | [2023/06] | English: | AMINOCYCLOBUTANES AS MONOACYLGLYCEROL LIPASE MODULATORS | [2023/06] | French: | AMINOCYCLOBUTANES SERVANT DE MODULATEURS DE LA MONOACYLGLYCÉROL LIPASE | [2023/06] | Entry into regional phase | 25.10.2022 | National basic fee paid | 25.10.2022 | Designation fee(s) paid | 25.10.2022 | Examination fee paid | Examination procedure | 25.10.2022 | Amendment by applicant (claims and/or description) | 25.10.2022 | Examination requested [2023/06] | 25.10.2022 | Date on which the examining division has become responsible | Fees paid | Renewal fee | 14.02.2023 | Renewal fee patent year 03 | 15.02.2024 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]US2017283406 (IKEDA SHUHEI [JP], et al) |